Harnessing Macrophage Lysosomal Lipid Metabolism in Obesity (ATM) | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Harnessing Macrophage Lysosomal Lipid Metabolism in Obesity (ATM)	Body Weight, Digestive System Diseases, Nutritional and Metabolic Diseases, Overweight, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, diabetes mellitus, endocrine system disorder, fatty liver disease, glucose metabolism disease, liver disorder, metabolic disease, metabolic dysfunction-associated steatotic liver disease, nutritional disorder, obesity disorder, overnutrition, type 2 diabetes mellitus	Recruiting	Not stated	2026-08-06		NCT06571474

4 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Bettina Mittendorfer	4
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)	617
National Institutes of Health (NIH)	667
Washington University School of Medicine	475

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
University of Missouri School of Medicine	Columbia	United States	9